# Harvard Bioscience Inc: Form 8-K, filed May 7, 2024

- Company: [Harvard Bioscience Inc](/companies/hbio.md) (CIK 1123494)
- Form: 8-K
- Filed: 2024-05-07
- Accepted by EDGAR: May 7, 2024, 07:00 ET
- Period: 2024-05-07
- Accession: 0001171843-24-002591
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1123494/000117184324002591/f8k_050724.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1123494/000117184324002591/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1123494/000117184324002591/f8k_050724.htm

Filed May 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001171843-24-002591. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.